Ensuring Diversity in COVID Vaccine Trials

Read more

With significant variations in the effects of COVID-19 among various ethnic, racial, and minority groups, how do we ensure vaccine trials are accurately establishing efficacy and safety across all patient populations? Beyond the ethical considerations, diversity is a medical and scientific imperative. This peer-reviewed article identifies tools and considerations for achieving representative diversity in enrollment for COVID-19 vaccine registration trials.


Chief Development Officer
VP, Regulatory Science, Strategy and Innovation

Want to learn more about Worldwide Clinical Trials?